Provided by Tiger Fintech (Singapore) Pte. Ltd.

Scilex Holding Company

22.17
-0.6300-2.76%
Volume:239.68K
Turnover:5.46M
Market Cap:154.21M
PE:-1.57
High:23.91
Open:22.75
Low:22.00
Close:22.80
52wk High:41.30
52wk Low:3.60
Shares:6.96M
Float Shares:5.41M
Volume Ratio:1.62
T/O Rate:4.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.1311
EPS(LYR):-19.4321
ROE:--
ROA:-65.79%
PB:-0.62
PE(LYR):-1.14

Loading ...

Press Release: Semnur Pharmaceuticals, Inc. ("Semnur"), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, "Scilex"), and Denali Capital Acquisition Corp. Announce Approval from Denali's Shareholders of the Previously Announced Business Combination

Dow Jones
·
Sep 04

Denali Capital Acquisition Corp. Conducted Extraordinary General Meeting

Reuters
·
Sep 04

BRIEF-Scilex Holding Co - CEO Jaisim Shah Resigns - SEC Filing

Reuters
·
Aug 21

Scilex Holding Co - Jaisim Shah to Remain CEO of Semnur Pharmaceuticals - SEC Filing

THOMSON REUTERS
·
Aug 21

Scilex Holding- Semnur Pharmaceuticals, Denali Capital Acquisition Corp Entered Purchase Agreement With an Investor for $20 Mln Private Placement

THOMSON REUTERS
·
Aug 21

Scilex Holding Co: Proceeds to Advance Second Phase 3 Clinical Trial for the Development of SP-102

THOMSON REUTERS
·
Aug 21

Scilex Holding: Pursuant to Purchase Agreement Investor Agreed to Purchase 1.3 Mln Shares of Common Stock of Combined Co for $16.00 per Share

THOMSON REUTERS
·
Aug 21

Press Release: Scilex Holding Company (Nasdaq: SCLX) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc. ("Semnur"), and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement at $16.00 per share and Jaisim Shah, Scilex's CEO and President, Will be Dedicated to Semnur on a Full Time Basis to Rapidly Advance SP-102 to Regulatory Approval and Commercialization for the Treatment of Lumbosacral Radicular Pain (LRP)/Sciatica

Dow Jones
·
Aug 21

Scilex Holding Q2 EPS $(7.42) Misses $(0.91) Estimate, Sales $9.896M Miss $26.250M Estimate

Benzinga
·
Aug 14

Sector Update: Health Care Stocks Gain Wednesday Afternoon

MT Newswires Live
·
Aug 14

BRIEF-Scilex Announces S-4 Effectiveness for Denali–Semnur Merger Proposal

Reuters
·
Aug 13

Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex

GlobeNewswire
·
Aug 13

Scilex Holding Co expected to post a loss of 91 cents a share - Earnings Preview

Reuters
·
Aug 12

Denali Capital Acquisition Corp. Announces Amendment to Merger Agreement with Semnur Pharmaceuticals

Reuters
·
Jul 29

Scilex Holding Co - on July 22, Amends Merger Agreement With Denali Capital - SEC Filing

THOMSON REUTERS
·
Jul 23

Scilex Holding Company Announces Amendment to Merger Agreement with Denali Capital Acquisition Corp to Adjust Exchange Ratio and Merger Consideration

Reuters
·
Jul 23

Scilex Holding Co - Enters Stock Purchase Agreement With Tumim Stone Capital - SEC Filing

THOMSON REUTERS
·
Jul 23

Scilex Holding Company Enters $100M Equity Line of Credit with Tumim Stone Capital and Executes Warrant Exchange Agreements

Reuters
·
Jul 23